No drugs for prions: could new approaches alleviate therapeutic scarcity?
The development of therapeutics for transmissible spongiform encephalopathies (TSEs) continues to be challenged by the complex nature of these diseases.…
homepage top section
-
-
How close are we to getting a male contraceptive?
With advances in clinical studies evaluating male contraceptives, and laws restricting abortion access after Roe v. Wade was overturned in…
-
Alopecia: Can new treatments pass the innovation and safety bar?
Last Friday, the US FDA decided to keep the popular anti-baldness drug finasteride on the market, but is now requiring…
-
The opioid epidemic: is pharma doing enough to develop treatments for the crisis?
The unique needs of an ongoing opioid crisis have pushed researchers to innovate while developing approaches to treat substance use…
-
Continuous manufacturing builds on hype but adoption remains gradual
The enthusiasm to build strong, sustainable supply chains only has only increased in the last few years following Brexit and…
-
Covid-19 patent lawsuits: Will vaccine producers have to pay the bill?
In a new chapter with emerging legal dimensions for the Covid-19 vaccine success story, last week Moderna submitted a filing…
-
Access to CAR-T therapies in Central and Eastern Europe in “catch-up” mode compared to the West
Certain EU member states in Central and Eastern Europe still struggle to access chimeric antigen receptor (CAR)-T cell therapies compared…
